Genetic variability in insulin action inhibitor Ikkβ (IKBKB) does not play a major role in the development of type 2 diabetes

Claudia Menzaghi, Nattachet Plengvidhya, Ma Xiaowei, James H. Warram, Steven E. Shoelson, Alessandro Doria

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Genetic variability in insulin action inhibitor Ikkβ (IKBKB) does not play a major role in the development of type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds